Endoscopic palliation of pancreatic cancer

Cancer Journal (United States)

Volumn 18, Issue 6, 2012, Pages 584-590

  Coté, Gregory A ^a   Sherman, Stuart ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

endoscopic retrograde cholangiopancreatography; endoscopic ultrasound; Pancreatic cancer; stent

Indexed keywords

ANTIBIOTIC AGENT; BILIRUBIN; OPIATE;

ADVANCED CANCER; BILIARY TRACT DRAINAGE; BILIRUBIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CELIAC PLEXUS; CELL FUNCTION; CHOLESTASIS; DUODENUM OBSTRUCTION; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPY; HUMAN; HYPERBILIRUBINEMIA; LIVER CELL; NEEDLE BIOPSY; NEUROLYSIS; PAIN; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PANCREATICODUODENECTOMY; PREOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SPINAL CORD DISEASE; STENT; STOMACH OBSTRUCTION; SYSTEMIC THERAPY; TREATMENT RESPONSE;

BILIARY TRACT SURGICAL PROCEDURES; CARCINOMA, PANCREATIC DUCTAL; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DRAINAGE; HUMANS; JAUNDICE, OBSTRUCTIVE; PALLIATIVE CARE; PANCREATIC NEOPLASMS; STENTS;

EID: 84871188604     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e3182745ad4     Document Type: Review

References (74)

1. Ross WA, Wasan SM, Evans DB, et al. Combined EUS with FNA and ERCP for the evaluation of patients with obstructive jaundice from presumed pancreatic malignancy. Gastrointest Endosc. 2008;68:461-466.
2. Moss AC, Morris E, Leyden J, et al. Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev. 2007;33:213-221.
3. Ballinger AB, McHugh M, Catnach SM, et al. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut. 1994; 35:467-470.
4. Pereira-Lima JC, Jakobs R, Maier M, et al. Endoscopic stenting in obstructive jaundice due to liver metastases: does it have a benefit for the patient? Hepatogastroenterology. 1996;43:944-948.
5. Moss AC, Morris E, MacMathuna P. Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev. 2006(2):CD004200.
6. Arguedas MR, Heudebert GH, Stinnett AA, et al. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis. Am J Gastroenterol. 2002;97:898-904.
7. Yeoh KG, Zimmerman MJ, Cunningham JT, et al. Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest Endosc. 1999;49:466-471.
8. Davids PH, Groen AK, Rauws EA, et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;340:1488-1492.
9. Prat F, Chapat O, Ducot B, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc. 1998;47:1-7.
10. Lillemoe KD. Preoperative biliary drainage and surgical outcome. Ann Surg. 1999;230:143-144.
11. Wang Q, Gurusamy KS, Lin H, et al. Preoperative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev. 2008(3):CD005444.
12. van der Gaag NA, Rauws EA, van Eijck CH, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010; 362:129-137.
13. Povoski SP, Karpeh MS Jr, Conlon KC, et al. Preoperative biliary drainage: impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy. J Gastrointest Surg. 1999;3: 496-505.
14. Eshuis WJ, van der Gaag NA, Rauws EA, et al. Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Ann Surg. 2010;252:840-849.
15. Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38-46.
16. Gerhards MF, van Gulik TM, de Wit LT, et al. Evaluation of morbidity and mortality after resection for hilar cholangiocarcinomaVa single center experience. Surgery. 2000;127:395-404.
17. Pitt HA, Gomes AS, Lois JF, et al. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg. 1985;201:545-553.
18. Hatfield AR, Tobias R, Terblanche J, et al. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet. 1982;2:896-899.
19. Lai EC, Mok FP, Fan ST, et al. Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg. 1994;81:1195-1198.
20. Wig JD, Kumar H, Suri S, et al. Usefulness of percutaneous transhepa-tic biliary drainage in patients with surgical jaundiceVa prospective randomised study. J Assoc Physicians India. 1999;47:271-274.
21. McPherson GA, Benjamin IS, Hodgson HJ, et al. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg. 1984;71:371-375.
22. Gouma DJ, Coelho JC, Schlegel JF, et al. The effect of preoperative internal and external biliary drainage on mortality of jaundiced rats. Arch Surg. 1987;122:731-734.
23. Clements WD, McCaigue M, Erwin P, et al. Biliary decompression promotes Kupffer cell recovery in obstructive jaundice. Gut. 1996;38: 925-931.
24. Saitoh N, Hiraoka T, Uchino R, et al. Endotoxemia and intestinal muco-sal dysfunction after the relief of obstructive jaundice by internal and external drainage in rats. Eur Surg Res. 1995;27:11-18.
25. Lacaine F, Fourtanier G, Fingerhut A, et al. Surgical mortality and morbidity in malignant obstructive jaundice: a prospective multivariate analysis. Eur J Surg. 1995;161:729-734.
26. Armstrong CP, Dixon JM, Taylor TV, et al. Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg. 1984;71: 234-238.
27. Blamey SL, Fearon KC, Gilmour WH, et al. Prediction of risk in biliary surgery. Br J Surg. 1983;70:535-538.
28. Dixon JM, Armstrong CP, Duffy SW, et al. Upper gastrointestinal bleeding. A significant complication after surgery for relief of obstructive jaundice. Ann Surg. 1984;199:271-275.
29. Dixon JM, Armstrong CP, Duffy SW, et al. Factors affecting mortality and morbidity after surgery for obstructive jaundice. Gut. 1984;25:104.
30. Koyama K, Takagi Y, Ito K, et al. Experimental and clinical studies on the effect of biliary drainage in obstructive jaundice. Am J Surg. 1981; 142:293-299.
31. Pereiras RV Jr, Rheingold OJ, Huston D, et al. Relief of malignant obstructive jaundice by percutaneous insertion of a permanent prosthesis in the biliary tree. Ann Intern Med. 1978;89:589-593.
32. van Berkel AM, Bruno MJ, Bergman JJ, et al. A prospective randomized study of hydrophilic polymer-coated polyurethane versus polyethylene stents in distal malignant biliary obstruction. Endoscopy. 2003;35: 478-482.
33. Leung JW, Liu YL, Desta TD, et al. In vitro evaluation of antibiotic prophylaxis in the prevention of biliary stent blockage. Gastrointest Endosc. 2000;51:296-303.
34. Rees EN, Tebbs SE, Elliott TS. Role of antimicrobial-impregnated polymer and Teflon in the prevention of biliary stent blockage. J Hosp Infect. 1998;39:323-329.
35. Tringali A, Mutignani M, Perri V, et al. A prospective, randomized mul-ticenter trial comparing DoubleLayer and polyethylene stents for malignant distal common bile duct strictures. Endoscopy. 2003;35:992-997.
36. Speer AG, Cotton PB, MacRae KD. Endoscopic management of malignant biliary obstruction: stents of 10 French gauge are preferable to stents of 8 French gauge. Gastrointest Endosc. 1988;34:412-417.
37. Kahaleh M, Tokar J, Le T, et al. Removal of self-expandable metallic Wallstents. Gastrointest Endosc. 2004;60:640-644.
38. Shin HP, Kim MH, Jung SW, et al. Endoscopic removal of biliary self-expandable metallic stents: a prospective study. Endoscopy. 2006;38: 1250-1255.
39. Familiari P, Bulajic M, Mutignani M, et al. Endoscopic removal of malfunctioning biliary self-expandable metallic stents. Gastrointest Endosc. 2005;62:903-910.
40. Kahaleh M, Behm B, Clarke BW, et al. Temporary placement of covered self-expandable metal stents in benign biliary strictures: a new paradigm? (with video). Gastrointest Endosc. 2008;67:446-454.
41. Cho JH, Kim YJ, Kim HM, et al. A comparison of outcomes among secondary covered, uncovered metalic and plastic stent for occluded biliary metallic stent for malignant distal biliary obstruction. Gastrointest Endosc. 2009;69:Ab136.
42. Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53:729-734.
43. Kullman EP, Soderlund C, Linder S, et al. Covered (cSEMS) versus uncovered (uSEMS) nitinol self-expandable metal stent in the palliative treatment of malignant distal biliary obstruction: preliminary results from a randomized controlled multicenter trial. Gastrointest Endosc. 2009;69: AB132.
44. Yoon WJ, Lee JK, Lee KH, et al. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc. 2006;63:996-1000.
45. Wasan SM, Ross WA, Staerkel GA, et al. Use of expandable metallic biliary stents in resectable pancreatic cancer. Am J Gastroenterol. 2005; 100:2056-2061.
46. Aadam AA, Evans DB, Khan A, et al. Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study. Gastro-intest Endosc. 2012;76:67-75.
47. Decker C, Christein JD, Phadnis MA, et al. Biliary metal stents are superior to plastic stents for preoperative biliary decompression in pancreatic cancer. Surg Endosc. 2011;25:2364-2367.
48. Isayama H, Kawabe T, Nakai Y, et al. Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction. Clin Gastroenterol Hepatol. 2006;4:1148-1153.
49. Chen VK, Arguedas MR, Baron TH. Expandable metal biliary stents before pancreaticoduodenectomy for pancreatic cancer: a Monte-Carlo decision analysis. Clin Gastroenterol Hepatol. 2005;3:1229-1237.
50. Del Piano M, Ballare M, Montino F, et al. Endoscopy or surgery for malignant GI outlet obstruction? Gastrointest Endosc. 2005;61:421-426.
51. Espinel J, Sanz O, Vivas S, et al. Malignant gastrointestinal obstruction: endoscopic stenting versus surgical palliation. Surg Endosc. 2006;20: 1083-1087.
52. Fiori E, Lamazza A, Volpino P, et al. Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stent-ing. A randomized prospective trial. Anticancer Res. 2004;24:269-271.
53. Johnsson E, Thune A, Liedman B. Palliation of malignant gastroduo-denal obstruction with open surgical bypass or endoscopic stenting: clinical outcome and health economic evaluation. World J Surg. 2004; 28:812-817.
54. Mehta S, Hindmarsh A, Cheong E, et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc. 2006;20:239-242.
55. Jeurnink SM, Steyerberg EW, van Hooft JE, et al. Surgical gastrojeju-nostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc. 2010;71:490-499.
56. Cote GA, Edmundowicz SA. Gastroduodenal and colonic endopros-theses. In: Ginsberg GG, Gostout CJ, Kochman ML, et al, eds. Clinical Gastrointestinal Endoscopy. 2nd ed. St Louis, MO: Elsevier Saunders; 2012:749-754.
57. Telford JJ, Carr-Locke DL, Baron TH, et al. Palliation of patients with malignant gastric outlet obstruction with the enteral wallstent: outcomes from a multicenter study. Gastrointest Endosc. 2004;60:916-920.
58. Dormann A, Meisner S, Verin N, et al. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy. 2004;36:543-550.
59. Arcidiacono PG, Calori G, Carrara S, et al. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev. 2011(3): CD007519.
60. Ascunce G, Ribeiro A, Reis I, et al. EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with pancreatic malignancy (with video). Gastrointest Endosc. 2011;73:267-274.
61. Sakamoto H, Kitano M, Kamata K, et al. EUS-guided broad plexus neurolysis over the superior mesenteric artery using a 25-gauge needle. Am J Gastroenterol. 2010;105:2599-2606.
62. Iwata K, Yasuda I, Enya M, et al. Predictive factors for pain relief after endoscopic ultrasoundYguided celiac plexus neurolysis. Dig Endosc. 2011;23:140-145.
63. Fujii L, Clain JE, Morris JM, et al. Anterior spinal cord infarction with permanent paralysis following endoscopic ultrasound celiac plexus neu-rolysis. Endoscopy. 2012;44(suppl 2):E265-E266.
64. LeBlanc JK, Al-Haddad M, McHenry L, et al. A prospective, randomized study of EUS-guided celiac plexus neurolysis for pancreatic cancer: one injection or two? Gastrointest Endosc. 2011;74:1300-1307.
65. Wiechowska-Kozlowska A, Boer K, Wojcicki M, et al. The efficacy and safety of endoscopic ultrasoundYguided celiac plexus neurolysis for treatment of pain in patients with pancreatic cancer. Gastroenterol Res Pract. 2012;2012:503098.
66. Wyse JM, Carone M, Paquin SC, et al. Randomized, double-blind, controlled trial of early endoscopic ultrasoundYguided celiac plexus neuroly-sis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol. 2011;29:3541-3546.
67. Ammar T, Cote GA, Creach KM, et al. Fiducial placement for stereo-tactic radiation by using EUS: feasibility when using a marker compatible with a standard 22-gauge needle. Gastrointest Endosc. 2010;71: 630-633.
68. Pishvaian AC, Collins B, Gagnon G, et al. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc. 2006;64:412-417.
69. Sanders MK, Moser AJ, Khalid A, et al. EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer. Gastrointest Endosc. 2010;71:1178-1184.
70. Varadarajulu S, Trevino JM, Shen S, et al. The use of endoscopic ultrasoundYguided gold markers in image-guided radiation therapy of pancreatic cancers: a case series. Endoscopy. 2010;42:423-425.
71. Seo DW. EUS-guided antitumor therapy for pancreatic tumors. Gut Liver. 2010;4(suppl 1):S76-S81.
72. Oh HC, Seo DW, Song TJ, et al. Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology. 2011;140:172-179.
73. Hecht JR, Farrell JJ, Senzer N, et al. EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc. 2012;75:332-338.
74. Costamagna G, Alevras P, Palladino F, et al. Endoscopic pancreatic stenting in pancreatic cancer. Can J Gastroenterol. 1999;13:481-487.